source
- Compass Pathways reports positive one-year data for its psilocybin therapy COMP360Compass Pathways released results from a one-year study of its psilocybin‑based therapy COMP360. The company described the data as positive, indicating continued promise for the investigational tre…
- TwoStep Therapeutics raises $62.5 million Series A backed by Pfizer and Merck KGaA venture groupsTwoStep Therapeutics, a cancer biotech, announced a $62.5 million Series A financing to advance its novel approach to antibody-drug conjugates and radioligand therapies. The round was supported by…